Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Keio University
Biopharma related deals can be found by searching the organization's name in the Deals Module.
BioCentury | Oct 10, 2024
Discovery & Translation
Science Spotlight: As miRNAs get Nobel Prize, targeting advances continue
BioCentury’s roundup of translational innovation also features Vedanta’s solution to GI infection, Takeda’s exon-skipping delivery tech, and more
BioCentury | Jun 10, 2023
Discovery & Translation
Bacteriophage therapy for liver dysfunction; plus Genentech’s pan-TEAD inhibitor and more
BioCentury’s roundup of translational news
BioCentury | May 14, 2019
Distillery Therapeutics
Two generic antifungals and cerivastatin for biliary, pancreatic cancers
BioCentury | Feb 22, 2019
Financial News
BiomX raises $32M series B to bring first two therapies to clinic
BioCentury | Feb 20, 2019
Financial News
BiomX raises $32M series B to bring first two therapies to clinic
BioCentury | Mar 1, 2018
Targets & Mechanisms
Checking out the microbiome
How academics are helping companies harness the microbiome for immuno-oncology
BioCentury | Feb 9, 2018
Product R&D
Debugging the microbiome
How BiomX is using bacteriophages to modulate the microbiome
Items per page:
1 - 10 of 53